Form 485BPOS TIMOTHY PLAN
Tweet
Share
E-mailhttp://archive.fast-edgar.com/20260128/ALZXN22CZ22TJ9Z2222R2ZZIF8WMZZ2IF282
Filed on: January 28, 2026
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Pentair Appoints Louis Pinkham to Board of Directors
- Merck Launches Your Hive of Whole Health to Support Whole Person Care for People Living With HIV
- IMPACT Therapeutics and Pharmanovia Announce Positive CHMP Opinion for Senaparib, as a Potential First-Line Maintenance Treatment of Advanced High-Grade Epithelial Ovarian, Fallopian Tube, and Primary
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
